The Swiss Medical Board has ceased its activities.

The website remains available but is no longer updated after June 30, 2022.

DE | EN | FR
  1. Home
  2. Projects & Results
  3. HTA reports
  4. Completed reports

Completed reports

Statins for primary prevention of cardiovascular disease (2013)

The Swiss Medical Board has published new recommendations for the use of statins as primary prevention of cardiovascular disease. In its report, the...

Read more

Systematic mammography screening (2013)

The Swiss Medical Board specialist committee has investigated the extent to which systematic mammography screenings meet the criteria of...

Read more

Transferability of an HTA report of the IQWiG (the German Institute for quality and efficiency in healthcare) to Switzerland – an investigation taking Ezetimibe for hypercholesterolemia as an example (2013)

How easy is it to apply reports from foreign HTA institutions to Swiss circumstances? The question was examined by the Swiss Medical Board (SMB)...

Read more

Significance of PSA level in early diagnosis of prostate cancer (2011)

The measurement of prostate-specific antigens (PSA test) is usually carried out with a view to the early diagnosis of prostate cancer, the most common...

Read more